This is a Commentary on Black et al. (J Bone Miner Res. 2012:27:243-254. DOI: 10.1002/jbmr.1494).
Bisphosphonate therapy for osteoporosis: The long and short of it†
Article first published online: 23 JAN 2012
Copyright © 2012 American Society for Bone and Mineral Research
Journal of Bone and Mineral Research
Volume 27, Issue 2, pages 240–242, February 2012
How to Cite
Compston, J. E. and Bilezikian, J. P. (2012), Bisphosphonate therapy for osteoporosis: The long and short of it. J Bone Miner Res, 27: 240–242. doi: 10.1002/jbmr.1542
- Issue published online: 23 JAN 2012
- Article first published online: 23 JAN 2012
- 1U.S. Food and Drug Administration. September 9, 2011: Joint Meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement [Internet]. Silver Spring (MD): U.S. Food and Drug Administration [cited 2012 Jan 3]. Available from: http://www.fda.gov/AdvisoryCommittees/Calendar/ucm262477.htm.
- 3American Society for Bone and Mineral Research. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2010; 25(11): 2267–94., , , , , , , , , , , , , , , , , , , , , , , , , ,